Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2014 (2014), Article ID 580320, 7 pages
http://dx.doi.org/10.1155/2014/580320
Research Article

Prophylactic Antioxidant Potential of Gallic Acid in Murine Model of Sepsis

1Siddhartha Institute of Pharmacy, Near I.T. Park, Sahastradhara Road, Dehradun, India
2City Heart Centre, 19 Cross Road, Dehradun 248001, India
3Nova College Pharmacy, Vegavaram, Jangareddigudem, Andhra Pradesh 534447, India

Received 12 February 2014; Revised 11 May 2014; Accepted 12 May 2014; Published 11 June 2014

Academic Editor: Madhav Bhatia

Copyright © 2014 Harikesh Maurya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Winterbourn, H. Buss, T. P. Chan, L. D. Plank, M. A. Clark, and J. A. Windsor, “Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients,” Critical Care Medicine, vol. 28, no. 1, pp. 143–149, 2000. View at Google Scholar · View at Scopus
  2. M. Andrades, C. Ritter, J. C. F. Moreira, and F. Dal-Pizzol, “Oxidative parameters differences during non-lethal and lethal sepsis development,” Journal of Surgical Research, vol. 125, no. 1, pp. 68–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Barichello, J. J. Fortunato, A. M. Vitali et al., “Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation,” Critical Care Medicine, vol. 34, no. 3, pp. 886–889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Geoghegan, D. McAuley, S. Eaton, and J. Powell-Tuck, “Selenium in critical illness,” Current Opinion in Critical Care, vol. 12, no. 2, pp. 136–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. U. Becker, C. Theodosis, S. T. Jacob, C. R. Wira, and N. E. Groce, “Surviving sepsis in low-income and middle-income countries: new directions for care and research,” The Lancet Infectious Diseases, vol. 9, no. 9, pp. 577–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Wenzel, “Treating sepsis,” The New England Journal of Medicine, vol. 347, no. 13, pp. 966–967, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Johnston Jr., B. B. Keele, H. P. Misra et al., “The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes,” The Journal of Clinical Investigation, vol. 55, no. 6, pp. 1357–1372, 1975. View at Google Scholar
  8. R. B. Johnston Jr., “Oxygen metabolism and the microbicidal activity of macrophages,” Federation Proceedings, vol. 37, no. 13, pp. 2759–2764, 1978. View at Google Scholar · View at Scopus
  9. J. Monteseirin, M. J. Camacho, I. Bonilla et al., “Respiratory burst in neutrophils from asthmatic patients,” Journal of Asthma, vol. 39, no. 7, pp. 619–624, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. W. L. Hand, D. L. Hand, and Y. Vasquez, “Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 76, no. 1, pp. 44–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Neuroinflammation Working Group, “Inflamation and Alzheimer’s disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–387, 2000. View at Publisher · View at Google Scholar
  12. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Kumar and A. Sharma, “Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed,” Journal of Chemotherapy, vol. 20, no. 6, pp. 672–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ebersoldt, T. Sharshar, and D. Annane, “Sepsis-associated delirium,” Intensive Care Medicine, vol. 33, no. 6, pp. 941–950, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Woiciechowsky, B. Schoning, W. R. Lanksch, H.-D. Volk, and W.-D. Docke, “Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression,” Journal of Molecular Medicine, vol. 77, no. 11, pp. 769–780, 1999. View at Google Scholar · View at Scopus
  16. R. Dantzer, J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, “From inflammation to sickness and depression: when the immune system subjugates the brain,” Nature Reviews Neuroscience, vol. 9, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Padkin, C. Goldfrad, A. R. Brady, D. Young, N. Black, and K. Rowan, “Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland,” Critical Care Medicine, vol. 31, no. 9, pp. 2332–2338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Balk and R. A. Balk, “Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations,” Critical Care Clinics, vol. 16, no. 2, pp. 179–192, 2000. View at Google Scholar · View at Scopus
  19. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, “The epidemiology of sepsis in the United States from 1979 through 2000,” The New England Journal of Medicine, vol. 348, no. 16, pp. 1546–1554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-Y. Ow and I. Stupans, “Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes,” Current Drug Metabolism, vol. 4, no. 3, pp. 241–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Miyaji, X. Hu, P. S. T. Yuen et al., “Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice,” Kidney International, vol. 64, no. 5, pp. 1620–1631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. G. Remick, D. E. Newcomb, G. L. Bolgos, and D. R. Call, “Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture,” Shock, vol. 13, no. 2, pp. 110–116, 2000. View at Google Scholar · View at Scopus
  23. K. A. Wichterman, A. Baue, and I. H. Chaudry, “Sepsis and septic shock: a review of laboratory models and a proposal,” Journal of Surgical Research, vol. 29, no. 2, pp. 189–201, 1980. View at Google Scholar · View at Scopus
  24. M. W. Merx, E. A. Liehn, U. Janssens et al., “HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis,” Circulation, vol. 109, no. 21, pp. 2560–2565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Reijnen, J. F. Meis, V. A. Postma, and H. van Goor, “Prevention of intra-abdominal abscesses and adhesions using a hyaluronic acid solution in a rat peritonitis model,” Archives of Surgery, vol. 134, no. 9, pp. 997–1001, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. I. H. de Hingh, B. M. de Man, R. M. Lomme, H. van Goor, and T. Hendriks, “Colonic anastomotic strength and matrix metalloproteinase activity in an experimental model of bacterial peritonitis,” British Journal of Surgery, vol. 90, no. 8, pp. 981–988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Reijnen, B. M. de Man, T. Hendriks, V. A. Postma, J. F. Meis, and H. van Goor, “Hyaluronic acid-based agents do not affect anastomotic strength in the rat colon, in either the presence or absence of bacterial peritonitis,” British Journal of Surgery, vol. 87, no. 9, pp. 1222–1228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. F. R. Dijkstra, M. Nieuwenhuijzen, M. M. Reijnen, and H. van Goor, “Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions,” Scandinavian Journal of Gastroenterology, Supplement, vol. 35, no. 232, pp. 52–59, 2000. View at Google Scholar · View at Scopus
  29. D. Rittirsch, M. S. Huber-Lang, M. A. Flierl, and P. A. Ward, “Immunodesign of experimental sepsis by cecal ligation and puncture,” Nature Protocols, vol. 4, no. 1, pp. 31–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-J. Li, S. Kahl, D. Carbaugh, and T. H. Elsasser, “Temporal response of liver signal transduction elements during in vivo endotoxin challenge in cattle: effects of growth hormone treatment,” Domestic Animal Endocrinology, vol. 32, no. 2, pp. 79–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. El-Demerdash, Y. Dewer, R. H. ElMazoudy, and A. A. Attia, “Kidney antioxidant status, biochemical parameters and histopathological changes induced by methomyl in CD-1 mice,” Experimental and Toxicologic Pathology, vol. 65, no. 6, pp. 897–901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Jafari, M. Salehi, A. Asgari et al., “Effects of paraoxon on serum biochemical parameters and oxidative stress induction in various tissues of Wistar and Norway rats,” Environmental Toxicology and Pharmacology, vol. 34, no. 3, pp. 876–887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Shafiq-ur-Rehman, S. Rehman, O. Chandra, and M. Abdulla, “Evaluation of malondialdehyde as an index of lead damage in rat brain homogenates,” BioMetals, vol. 8, no. 4, pp. 275–279, 1995. View at Google Scholar · View at Scopus
  34. M. Madesh and K. A. Balasubramanian, “Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide,” Indian Journal of Biochemistry & Biophysics, vol. 35, no. 3, pp. 184–188, 1998. View at Google Scholar · View at Scopus
  35. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Google Scholar · View at Scopus
  36. O. Arunlakshana, H. O. Schild, and D. H. Jenkinson, “Some quantitative uses of drug antagonists,” British Journal of Pharmacology, vol. 120, supplement 1, pp. 148–150, 1997. View at Publisher · View at Google Scholar
  37. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Google Scholar
  38. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, pp. 192–205, 1968. View at Google Scholar · View at Scopus
  39. H. Babaei, O. Sadeghpour, L. Nahar et al., “Antioxidant and vasorelaxant activities of flavonoids from Amygdalus lycioides var. horrid,” Turkish Journal of Biological Sciences, vol. 32, pp. 203–208, 2008. View at Google Scholar
  40. K. Sompamit, U. Kukongviriyapan, S. Nakmareong, P. Pannangpetch, and V. Kukongviriyapan, “Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice,” European Journal of Pharmacology, vol. 616, no. 1–3, pp. 192–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Kapoor, S. Basu, B. K. Das, and B. D. Bhatia, “Lipid peroxidation and antioxidants in neonatal septicemia,” Journal of Tropical Pediatrics, vol. 52, no. 5, pp. 372–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Mühl, G. Woth, L. Drenkovics et al., “Comparison of oxidative stress & leukocyte activation in patients with severe sepsis & burn injury,” Indian Journal of Medical Research, Supplement, vol. 134, no. 1, pp. 69–78, 2011. View at Google Scholar · View at Scopus
  43. M. Andresen, T. Regueira, A. Bruhn et al., “Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock,” Mediators of Inflammation, vol. 2008, Article ID 168652, 8 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus